Evidence map›Paper›PMID 35768542›Full record

ArticleCommunications biology2022

Xtrapol8 enables automatic elucidation of low-occupancy intermediate-states in crystallographic studies.

Elke De Zitter, Nicolas Coquelle, Paula Oeser, Thomas R M Barends, Jacques-Philippe Colletier

Abstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. TheJournal of applied crystallography · 2025
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elke De ZitterUniv. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale, 38000, Grenoble, France.ORCID 0000-0001-6325-7354
Nicolas CoquelleEuropean Synchrotron Radiation Facility (ESRF), BP 220, 38043, Grenoble, France.
Paula OeserUniv. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale, 38000, Grenoble, France.ORCID 0000-0002-5431-3438
Thomas R M BarendsMax-Planck-Institut für medizinische Forschung, Jahnstrasse 29, 69120, Heidelberg, Germany.ORCID 0000-0002-9488-3005
Jacques-Philippe ColletierUniv. Grenoble Alpes, CEA, CNRS, Institut de Biologie Structurale, 38000, Grenoble, France. colletier@ibs.fr.ORCID 0000-0003-1819-4686

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unstable states studied in kinetic, time-resolved and ligand-based crystallography are often characterized by a low occupancy, which hinders structure determination by conventional methods. To automatically extract structural information pertaining to these states, we developed Xtrapol8, a program which (i) applies various flavors of Bayesian-statistics weighting to generate the most informative Fourier difference maps; (ii) determines the occupancy of the intermediate states by use of methods hitherto not available; (iii) calculates extrapolated structure factors using the various proposed formalisms while handling the issue of negative structure factor amplitudes, and (iv) refines the corresponding structures in real and reciprocal-space. The use of Xtrapol8 could accelerate data processing in kinetic and time-resolved crystallographic studies, and as well foster the identification of drug-targetable states in ligand-based crystallography.

Indexed as

CrystallographyBayes TheoremKineticsLigandsLigands

Identifiers

PMID35768542
PMCPMC9243118

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.